enGene Holdings Inc. logo

ENGN Earnings Date: Dec 22, 2026 (Estimated) — enGene Holdings Inc.

NASDAQ · Healthcare · Biotechnology

Updated

Price $1.53
Market Cap $102.5M
P/E -6.0
52W Range $1.40 – $12.25
Next Earnings · After close (est.)

When is ENGN's next earnings date?

enGene Holdings Inc. (ENGN) is expected to report Q4 2026 earnings on Tuesday, December 22, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.36.

How did ENGN do in its last earnings report?

In its most recent report on Sep 8, 2026 (Q3 2026), enGene Holdings Inc. posted EPS of -$0.47 versus the -$0.43 estimate, a miss of 6.8%. Revenue was $0. The stock's 1-day post-earnings move was +5.5%.

How much does ENGN stock move after earnings?

ENGN beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.2% (up or down) in the day after earnings.

About enGene Holdings Inc.

Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm. Its core mission involves pioneering genetic pharmaceuticals, achieved by administering therapeutic agents directly to mucosal tissues and other bodily organs. A key asset in its pipeline is EG-70, also known as detalimogene voraplasmid. This innovative non-viral immunotherapy is being developed to treat non-muscle invasive bladder cancer in patients diagnosed with carcinoma-in-situ (Cis) who have shown no improvement after Bacillus Calmette-Guérin therapy. The company was established in 2023 and is headquartered in Saint-Laurent, Canada.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-09-08Q3 2026-0.43-0.47-6.82%$0❌ Miss+5.49%+2.75%-1.10%
2026-06-15Q2 2026-0.47-0.43+8.51%$0✅ Beat+9.26%+4.32%+17.28%
2026-03-09Q1 2026-0.56-0.44+21.43%$0✅ Beat-18.78%-17.51%-15.55%
2025-12-22Q4 2025-0.57-0.73-28.07%$0❌ Miss+5.13%+2.05%+38.77%
2025-09-11Q3 2025-0.50-0.57-14.00%$0❌ Miss-5.78%+14.85%+38.45%
2025-06-12Q2 2025-0.40-0.51-27.50%—❌ Miss+0.93%+2.17%+3.73%
2025-03-10Q1 2025-0.38-0.48-26.32%$0❌ Miss-1.72%-2.10%-21.37%
2024-12-19Q4 2024-0.41-0.34+17.07%$0✅ Beat-2.18%+7.72%+22.32%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .